Dr. Badr continues to lead the pathology department and Core Medical Laboratory, a division of NYCBS that is at the forefront of improved healthcare and an integral part of patient outcomes.
Over the years, there has been a growing justified recognition and impetus to avoid overtreatment, particularly for those who present with early-stage low grade (i.e., nonaggressive) disease.